about
Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration.Adenosine Deaminase-2-Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3pContribution of TNF-α to the development of retinal neurodegenerative disorders.The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment.The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms.Anti-inflammatory role of sesamin in STZ induced mice model of diabetic retinopathy.Hyperhomocysteinemia Alters Retinal Endothelial Cells Barrier Function and Angiogenic Potential via Activation of Oxidative Stress.Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways.Protective effects of L-carnosine on CCl4 -induced hepatic injury in rats.Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke.Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy.Naringin attenuates thioacetamide-induced liver fibrosis in rats through modulation of the PI3K/Akt pathway.Anti-tumor activity of arjunolic acid against Ehrlich Ascites Carcinoma cells in vivo and in vitro through blocking TGF-β type 1 receptor.Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1.Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats.Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer.Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy.Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration.Corrigendum to "Crocin protects against doxorubicin-induced myocardial toxicity in rats through down-regulation of inflammatory and apoptic pathways" [Chemico-Biol. Interact. 247 (2016) 39-48].Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis.Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapyThe co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesisClinical significance of the TNF-α receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemiaAntioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in ratsInhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediatorsEvaluation of renal protective effects of inhibiting TGF-β type I receptor in a cisplatin-induced nephrotoxicity model
P50
Q36217669-21BD87DD-9378-4858-BC77-931AE5EC5CFCQ36962338-0D268A9E-3024-4C06-8E1C-41CC8045A4FEQ37634192-03B16B30-5E14-4A33-8A1E-3225A5CA0290Q38100910-0A8AF3FC-A234-4D64-BE50-B0AC9C6FEB56Q38719998-43F1204A-3158-4492-A191-A86E75744177Q38753727-A534E17E-ABDB-4388-80DA-DE71AA04690BQ38821085-78783287-AFE1-431F-ADF2-5E10A9277B65Q38993712-DE3F0904-9798-4A45-A3A0-55262525C199Q39729596-AF328D49-56BE-4587-877E-033FC34F430CQ41696995-A87474BF-F1F2-46F6-A561-8655ED65147BQ46163340-A587C01E-05FE-4BBF-8C95-E30DC2590BBEQ46203812-8FB91699-672E-459F-BA92-85B3983C79B1Q46269921-326B2CDE-542D-4A21-AF77-2BE7B45B2FFDQ46805659-62B82828-74E8-4FDE-93AA-3EFDB95DCF74Q46828930-7D69D6AA-8319-46DB-AADF-50E6AE5F2C89Q46873009-FF89F26C-4875-4D64-9EFF-EB777BAFB8DDQ46946350-5353D071-E83B-4448-A44D-81F1EFD93CCFQ47240755-8C32B49C-5643-44C3-A1AD-A9C7AC4B1462Q51256674-19F72E30-2AC7-4910-94BE-3CFCFFAC783AQ51718216-C20A162D-1ED4-40AC-91B0-A94C709B622CQ52731094-25430235-DA08-4A40-A9C2-C83A6965D5ECQ53294905-5045DB22-693D-4DB6-BC09-F205825C4637Q53699893-74004204-9BAF-454B-B413-0D62B3A7029BQ53766690-9BD50453-F78A-4B13-9C6C-871D278562B8Q55036124-328D0B92-D274-4B8A-A1EB-C56011EFBBD7Q58129962-778B90BC-8BE3-43BC-923D-4A1D14485948Q61917624-41969F3D-1B14-46DF-9D96-04F2520F7C05Q88965216-E9298E1E-2119-4838-ABE6-085ADB43949FQ91107064-3F87C3ED-CC6C-4D51-B3B9-AF831EEBBE55Q91741485-7B485CBF-8EF1-4B64-9902-B1B839147D46Q95560909-0B0AAC4E-99C0-4B5D-9080-9726416DC512
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nehal M Elsherbiny
@ast
Nehal M Elsherbiny
@en
Nehal M Elsherbiny
@es
Nehal M Elsherbiny
@nl
type
label
Nehal M Elsherbiny
@ast
Nehal M Elsherbiny
@en
Nehal M Elsherbiny
@es
Nehal M Elsherbiny
@nl
prefLabel
Nehal M Elsherbiny
@ast
Nehal M Elsherbiny
@en
Nehal M Elsherbiny
@es
Nehal M Elsherbiny
@nl
P106
P31
P496
0000-0001-5167-3377